ZANGRILLI, ARIANNA
 Distribuzione geografica
Continente #
NA - Nord America 5.404
EU - Europa 489
AS - Asia 307
OC - Oceania 5
AF - Africa 3
SA - Sud America 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.212
Nazione #
US - Stati Uniti d'America 5.399
SG - Singapore 144
CN - Cina 105
IE - Irlanda 89
DE - Germania 78
SE - Svezia 67
IT - Italia 57
RU - Federazione Russa 54
UA - Ucraina 52
FR - Francia 36
GB - Regno Unito 32
KR - Corea 17
UZ - Uzbekistan 12
FI - Finlandia 11
IN - India 8
KG - Kirghizistan 7
AU - Australia 5
CA - Canada 4
BE - Belgio 3
HK - Hong Kong 3
NL - Olanda 3
RO - Romania 3
BR - Brasile 2
CH - Svizzera 2
EG - Egitto 2
ID - Indonesia 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BG - Bulgaria 1
EU - Europa 1
IL - Israele 1
IQ - Iraq 1
IR - Iran 1
JP - Giappone 1
KH - Cambogia 1
MA - Marocco 1
MD - Moldavia 1
MX - Messico 1
MY - Malesia 1
PH - Filippine 1
TR - Turchia 1
Totale 6.212
Città #
Wilmington 1.582
Houston 1.274
Woodbridge 1.155
Fairfield 236
Chandler 199
Singapore 126
Ashburn 122
Ann Arbor 109
Seattle 96
Cambridge 88
Dublin 84
Medford 62
Dearborn 46
Jacksonville 43
Lawrence 29
Beijing 28
New York 25
Santa Clara 24
Zhengzhou 18
San Diego 17
Moscow 12
Rome 12
Shanghai 11
Munich 10
Boardman 9
Hefei 8
Seoul 8
Menlo Park 7
Norwalk 7
Redmond 7
Redwood City 7
Esslingen am Neckar 5
Jinan 4
Kilburn 4
Nanjing 4
Palo Alto 4
Sedico 4
Sydney 4
Augusta 3
Brussels 3
Detroit 3
Genazzano 3
Guangzhou 3
London 3
Mülheim 3
Nanchang 3
Paris 3
Aprilia 2
Atlanta 2
Bari 2
Bologna 2
Cairo 2
Central 2
Coimbatore 2
Falls Church 2
Fuzhou 2
Giugliano In Campania 2
Guidonia 2
Hebei 2
Jakarta 2
Joliet 2
Kunming 2
Milan 2
Nürnberg 2
Pune 2
Saint Petersburg 2
San Francisco 2
Shenyang 2
Stockertown 2
Stockport 2
Suceava 2
Sundern 2
Toronto 2
Wuhan 2
Acton 1
Albano Laziale 1
Ankara 1
Ardabil 1
Auburn Hills 1
Bellingham 1
Boston 1
Büdelsdorf 1
Chengdu 1
Chicago 1
Chisinau 1
Clearwater 1
Council Bluffs 1
Dubai 1
Grezzago 1
Groningen 1
Guadalajara 1
Hangzhou 1
Helsinki 1
Hounslow 1
Kuala Lumpur 1
Lappeenranta 1
Las Vegas 1
Latina 1
Leawood 1
Manila 1
Totale 5.597
Nome #
Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study 423
Adalimumab in the treatment of plaque-type psoriasis and psoriatic arthritis 394
Real-life 9-year experience with adalimumab in psoriasis and psoriatic arthritis: results of a single-centre, retrospective study. 392
HLA-C*06:02 Does Not Predispose to Clinical Response Following Long-Term Adalimumab Treatment in Psoriatic Patients: A Retrospective Cohort Study. 385
Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics 384
Quality of life of psoriatic patients evaluated by a new psychometric assessment tool: PsoDisk 357
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey 349
TNF-α antagonists and nail psoriasis: An open, 24-week, prospective cohort study in adult patients with psoriasis 348
Erysipeloid cutaneous metastasis from bladder carcinoma 341
Long-term treatment of psoriatic patients with adalimumab reduces disease severity and maintains a favorable lipid pattern and a low Atherogenic Index. 319
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey 299
Radiologically significant joint improvement in a patient affected by psoriatic arthritis treated with adalimumab 281
Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice 228
Paradoxical case effects of psoriasis following adalimumab therapy: A case series 223
Adalimumab in severe plaque psoriasis of childhood: A multi-center, retrospective real-life study up to 52 weeks observation 210
One drug and two diseases: A case of multidrug-resistant hidradenitis suppurativa and psoriasis treated with apremilast 209
Adalimumab in children and adolescents with severe plaque psoriasis: a safety evaluation 154
Real life experience of apremilast in psoriasis and arthritis psoriatic patients: preliminary results on metabolic biomarkers 154
Efficacy and safety of Adalimumab in difficult-to-treat psoriasis 147
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations 117
Ixekizumab: One drug for an enigmatic psoriasis 99
Psoriasis in difficult to treat areas: treatment role in improving health-related quality of life and perception of the disease stigma 93
Omalizumab and adalimumab: a winning couple 90
A linear forehead lesion caused by intralesional injection of triamcinolone acetonide and treated with hyaluronic acid filler: case report 78
Adalimumab for moderate to severe psoriasis: an open-label, retrospective 3-year study 68
Risankizumab: How to choose the right dose in clinical practice? 65
Paradoxical psoriasis induced by anti-TNFα treatment: evaluation of disease-specific clinical and genetic markers 61
Long-term efficacy of adalimumab in generalized pustular psoriasis 56
Clinical severity instruments 51
Effectiveness of risankizumab in the treatment of palmoplantar psoriasis: A 52-week Italian real-life experience 14
A multicenter study on effectiveness and safety of risankizumab in psoriasis: an Italian 16-week real-life experience during the COVID-19 pandemic 4
Improvement of Psoriasis Using Oral Probiotic Streptococcus salivarius K-12: a Case–Control 24-Month Longitudinal Study 1
Totale 6.394
Categoria #
all - tutte 16.348
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.348


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.056 0 0 0 0 0 188 169 143 127 188 113 128
2020/20211.380 108 124 116 155 204 191 176 159 44 44 36 23
2021/2022333 17 31 21 26 10 18 18 13 18 51 20 90
2022/2023456 36 51 24 54 38 98 38 23 49 13 18 14
2023/2024143 15 3 8 5 19 29 12 23 4 2 0 23
2024/2025287 28 119 93 28 6 13 0 0 0 0 0 0
Totale 6.394